Navigation Links
Costly Breast Cancer Screenings May Not Help Seniors: Study
Date:1/7/2013

By Kathleen Doheny
HealthDay Reporter

MONDAY, Jan. 7 (HealthDay News) -- Medicare spends more than $1 billion each year for breast cancer screenings such as mammography, according to a new study.

However, all that expenditure may not help produce better results for older women, said Dr. Cary Gross, an associate professor of internal medicine at Yale University School of Medicine. He also directs the Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center.

In the new study, Gross and his colleagues identified more than 137,000 women, aged 66 to 100, who had no history of breast cancer. Gross looked at the costs to fee-for-service Medicare for breast cancer screening during 2006-2007.

The study authors also looked at costs of screening in different regions.

Women living in areas with higher screening costs were as much as 78 percent more likely to be diagnosed with early-stage or in-situ breast cancer as women in regions spending less.

However, regardless of how much was spent on screening, it didn't make a difference in diagnosing late-stage cancers, the investigators found.

This suggests "overdiagnosis" of breast cancers in the regions spending the most on screening, Gross said. This means a cancer that was diagnosed may not have been problematic during a woman's lifetime. However, other experts argue that it's difficult to determine which cancers will become a threat to health.

The study is published online Jan. 7 in JAMA Internal Medicine.

The variation in screening costs by regions, Gross said, is driven by newer and more expensive screening technologies such as digital mammography and computer-aided detection. The costs varied greatly by region of the country, from $42 to $107 per person.

In older women, he said, research is lacking about whether the newer technologies produce better health outcomes.

The overall screening costs of a billion dollars annually are higher than previous researchers have found, Gross noted. He takes issue with Medicare's reimbursement strategy, which the study authors pointed out, "support rapid adoption of newer modalities [methods], frequently without adequate data to support their use."

"Our study is largely directed at policymakers," Gross said. For older women, he explained, the take-home message is this: "Getting more expensive tests for breast cancer does not necessarily produce a better outcome."

And he added, "Our study highlights the insanity of a system that pays substantially more for a new technology without any evidence that it is beneficial in the older population."

The co-author of an editorial accompanying the study, Dr. Jeanne Mandelblatt, a professor of medicine and associate director of population sciences at the Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C., said that the new study "is a call to action to get more research."

The findings, Mandelblatt said, raise the possibility that newer technology may not always be better for all women. Research on the breast cancer screening technologies in older women is lacking "because older women have not been included in sufficient numbers" in research studies, she said.

"One important message for older women is they need to get involved in research studies, they need to advocate for research studies," Mandelblatt said.

Another expert, Judith Malmgren, takes issue with the findings and the emphasis on late-stage cancer detection.

"By focusing only on stage 4, you are not evaluating the overall effectiveness of screening," said Malmgren, an affiliate faculty member with the department of epidemiology at the University of Washington School of Public Health, who has written about breast cancer screening.

"The purpose of mammography screening is to find early stage cancers," Malmgren said.

More information

To learn more about breast cancer, visit the U.S. National Cancer Institute.

SOURCES: Cary Gross, M.D., associate professor of internal medicine, Yale School of Medicine, and director, Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, Conn.; Jeanne S. Mandelblatt, M.D., M.P.H., professor of medicine and associate director for population sciences, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C.; Judith Malmgren, Ph.D., affiliate faculty, University of Washington School of Public Health, Seattle; Jan. 7, 2013, JAMA Internal Medicine, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Despite hype, costly prostate cancer treatment offers little relief from side effects
2. Communications training, surgical checklist can reduce costly postoperative complications
3. Costly, Repeat Medical Testing Common for Medicare Patients: Study
4. Policy considerations pose options for leaders to reduce costly disparities in diabetes
5. Less-experienced physicians more costly than more-experienced physicians
6. ASBMR task force urges use of fracture liaision services to reduce costly osteoporosis bone breaks
7. New process would make anti-malarial drug less costly
8. Availability of Beds, Poverty Drive Costly Hospital Readmissions
9. Breastfeeding tips women share intrigue doctors
10. Boost Your Bust: Review Examining Jenny Bolton's Breast Enlargement System Released by HonestyFirstReviews.com
11. Breast milk contains more than 700 bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Costly Breast Cancer Screenings May Not Help Seniors: Study
(Date:1/19/2017)... ... January 19, 2017 , ... ... has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound ... extension to RMT technology that delivers HD, dynamic, streaming ultrasound images and video ...
(Date:1/19/2017)... ... 19, 2017 , ... WholeHealth is announcing their participation in ... Andrew Petersen and Trish Henrie-Barrus will be present Saturday and Sunday in the ... , “We know it’s easy to get carried away when you’re having ...
(Date:1/19/2017)... Scotch Plains, NJ (PRWEB) , ... January 19, ... ... a board certified dermatologist by the American Board of Dermatology and fellowship trained ... Institute of the National Institutes of Health, Dr. Li completed his internship in ...
(Date:1/19/2017)... ... 2017 , ... Bio-Optronics Inc. is proud to announce the ... to seamlessly integrate and streamline the way researchers prepare and conduct patient visits. ... and improving efficiency significantly for users – a first in the CTMS industry. ...
(Date:1/19/2017)... San Antonio, Texas (PRWEB) , ... January 19, 2017 , ... ... entering the GenCure Tissue Donation Awareness Scholarship competition., The winner will earn a $1,000 ... media accounts. The competition begins Feb. 1, and the deadline is May 31, with ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... LONDON , January 20, 2017 Avillion ... the appointment of Mark Weinberg , MD MBA as Chief ... , USA . ... Dr Weinberg has spent more than 17 ... "top 20" pharma companies to micro-cap biotech. Over the course of ...
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... the Ophthalmic Devices Market? Which areas are going to ... you potential revenues to 2026, assessing data, trends, opportunities ... charts, and graphs. Discover the most lucrative areas in ... study lets you assess forecasted sales across the all ...
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
Breaking Medicine Technology: